Jean-Luc Raoul

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

Cancers

Current oncology (Toronto, Ont.)

Clinical case reports

Clinical Medicine Insights. Oncology

Institut de cancérologie de l'Ouest, Saint Herblain

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut de cancérologie de l'Ouest, Saint Herblain

France

Prof :: Medical Oncology

Publications

Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Elodie Martin, Karine Le Malicot, Catherine Guerin-Charbonnel, François Bocquet, Olivier Bouche, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology. Current oncology (Toronto, Ont.) 31 (6) (2024)
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Jean-Luc Raoul
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19). Cancers 15 (19) (2023)
Margaux Lelong, Jean-Luc Raoul, Yann Touchefeu, Jean-Marie Berthelot, Paul Arnolfo, Tamara Matysiak-Budnik, Hélène Senellart
Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis. Clinical case reports 10 (12) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Michèle Boisdron-Celle, Martine M Bellanger, Jean-Luc Raoul
COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19). Cancers 14 (22) (2022)
Margaux Lelong, Jean-Luc Raoul, Yann Touchefeu, Jean-Marie Berthelot, Paul Arnolfo, Tamara Matysiak-Budnik, Hélène Senellart
Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis. Clinical case reports 10 (12) (2022)
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Frédéric Bigot
COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19). Clinical Medicine Insights. Oncology 16 (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Julien Edeline, Tim Meyer, Jean-Frédéric Blanc, Jean-Luc Raoul
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations. Cancers 14 (23) (2022)
Jean-Luc Raoul, Julien Edeline, Victor Simmet, Camille Moreau-Bachelard, Marine Gilabert, Jean-Sébastien Frenel
Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper. Cancers 14 (5) (2022)
Camille Moreau-Bachelard, Valentin Letailleur, Emmanuelle Bompas, Patrick Soulié, Julie Paul, Jean-Luc Raoul
Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis. Cancers 14 (19) (2022)
Loig Vaugier, Xavier Mirabel, Isabelle Martel-Lafay, Séverine Racadot, Christian Carrie, Véronique Vendrely, Marc-André Mahé, Hélène Senellart, Jean-Luc Raoul, Loic Campion, Emmanuel Rio
Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer. Cancers 13 (2) (2021)
Ke Zhou, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Frédéric Bigot, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Jean-Luc Raoul
Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study. Cancers 13 (14) (2021)
Maeva Andriantsoa, Solene Hoibian, Aurelie Autret, Marine Gilabert, Anthony Sarran, Patricia Niccoli, Jean-Luc Raoul
An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value. PloS one 12 (5) (2017)

Jean-Luc Raoul.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Luc Raoul